Skip to main content
Home / Current Medicinal Chemistry, Volume 18, Number 19
Current Medicinal Chemistry covers all the latest and outstanding developments in medicinal chemistry and rational drug design. Each issue contains a series of timely in-depth reviews written by leaders in the field covering a range of the current topics in medicinal chemistry. Current Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments.

Publisher: Bentham Science Publishers

More about this publication?
Volume 18, Number 19, 2011

Articles

Editorial [Hot Topic: Protein Kinases in Cancer: Recent Findings (Guest Editor: Silvia Schenone)]
pp. 2826-2826(1)
Author: Schenone, Silvia

Favourites:
ADD

Cancer Multitarget Pharmacology in Prostate Tumors: Tyrosine Kinase Inhibitors and Beyond
pp. 2827-2835(9)
Authors: Bologna, M.; Vicentini, C.; Muzi, P.; Pace, G.; Angelucci, A.

Favourites:
ADD

Overcoming the Drug Resistance Problem with Second-Generation Tyrosine Kinase Inhibitors: From Enzymology to Structural Models
pp. 2836-2847(12)
Authors: Crespan, E.; Zucca, E.; Maga, G.

Favourites:
ADD

Protein Kinase Homology Models: Recent Developments and Results
pp. 2848-2853(6)
Authors: Tuccinardi, T.; Martinelli, Adriano

Favourites:
ADD

Peptides or Small Molecules? Different Approaches to Develop More Effective CDK Inhibitors
pp. 2854-2866(13)
Authors: Cirillo, D.; Pentimalli, F.; Giordano, A.

Favourites:
ADD

The Dark Side of Protein Kinase CK2 Inhibition
pp. 2867-2884(18)
Authors: Cozza, G.; Meggio, F.; Moro, S.

Favourites:
ADD

Role of the Hypoxic Microenvironment in the Antitumor Activity of Tyrosine Kinase Inhibitors
pp. 2885-2892(8)
Authors: Filippi, I.; Naldini, A.; Carraro, F.

Favourites:
ADD

Receptor Tyrosine Kinase Kit and Gastrointestinal Stromal Tumours: An Overview
pp. 2893-2903(11)
Authors: Sartini, S.; Dario, B.; Morelli, M.; Da Settimo, F.; La Motta, C.

Favourites:
ADD

Role of Phosphorylation in the Nuclear Biology of HIV-1
pp. 2904-2912(9)
Authors: C. Francis, A.; Di Primio, C.; Allouch, A.; Cereseto, A.

Favourites:
ADD

Role of the Non-Receptor Tyrosine Kinase Fes in Cancer
pp. 2913-2920(8)
Authors: Condorelli, F.; Stec-Martyna, E.; Zaborowska, J.; Felli, L.; Gemmi, I.; Ponassi, M.; Rosano, C.

Favourites:
ADD

Fyn Kinase in Brain Diseases and Cancer: The Search for Inhibitors
pp. 2921-2942(22)
Authors: Schenone, S.; Brullo, C.; Musumeci, F.; Biava, M.; Falchi, F.; Botta, M.

Favourites:
ADD

BCR-ABL Inhibitors in Chronic Myeloid Leukemia: Process Chemistry and Biochemical Profile
pp. 2943-2959(17)
Authors: Leonetti, F.; Stefanachi, A.; Nicolotti, O.; Catto, M.; Pisani, L.; Cellamare, S.; Carotti, A.

Favourites:
ADD

Targeting mTOR Signaling Pathway in Ovarian Cancer
pp. 2960-2968(9)
Authors: Mabuchi, S.; Hisamatsu, T.; Kimura, T.

Favourites:
ADD

An Original Deal for New Molecule: Reversal of Efflux Pump Activity, A Rational Strategy to Combat Gram-Negative Resistant Bacteria
pp. 2969-2980(12)
Authors: Pages, J.-M.; Amaral, L.; Fanning, S.

Favourites:
ADD

Share Content

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content